Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Complete Response × Immunohistochemistry × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 6 Rectal Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Colonic Neoplasms 5 Lymphoma, Large-Cell, Anaplastic 4 Lymphoma, Follicular 4 Immunoblastic Lymphadenopathy 4 Colorectal Neoplasms 4 Breast Neoplasms, Male 4 Sezary Syndrome 3 Mycosis Fungoides 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Mantle-Cell 3 Lymphoma, Extranodal NK-T-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Carcinoma, Renal Cell 3 Burkitt Lymphoma 3 Waldenstrom Macroglobulinemia 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Melanoma 2 Liver Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2

Interventions

temsirolimus 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pazopanib 1 olaparib 1 eltrombopag 1 cc-486 1 Surveys and Questionnaires 1 Nivolumab 1 Monatide (IMS 3015) 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Diphenhydramine 1 Cytarabine 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡